Globe Life (NYSE:GL) Issues Quarterly Earnings Results

Globe Life (NYSE:GLGet Free Report) posted its quarterly earnings data on Monday. The company reported $2.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.79 by ($0.01), Briefing.com reports. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Globe Life had a net margin of 18.07% and a return on equity of 23.91%. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the business earned $2.53 earnings per share. Globe Life updated its FY24 guidance to $11.50-12.00 EPS and its FY 2024 guidance to 11.500-12.000 EPS.

Globe Life Price Performance

Shares of GL opened at $75.79 on Wednesday. Globe Life has a 1-year low of $38.95 and a 1-year high of $132.00. The stock has a market cap of $7.13 billion, a PE ratio of 7.24 and a beta of 0.69. The firm has a 50-day simple moving average of $109.59 and a two-hundred day simple moving average of $116.08. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.05 and a quick ratio of 0.05.

Globe Life Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Friday, April 5th will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, April 4th. This is a boost from Globe Life’s previous quarterly dividend of $0.23. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.27%. Globe Life’s dividend payout ratio (DPR) is currently 9.17%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on GL. JPMorgan Chase & Co. raised their price target on shares of Globe Life from $133.00 to $136.00 and gave the stock an “overweight” rating in a research note on Thursday, February 8th. Truist Financial reissued a “hold” rating and issued a $125.00 price target on shares of Globe Life in a research note on Friday, April 12th. Evercore ISI decreased their price target on shares of Globe Life from $125.00 to $75.00 and set an “in-line” rating on the stock in a research note on Friday, April 12th. Piper Sandler decreased their price target on shares of Globe Life from $143.00 to $130.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Finally, StockNews.com downgraded shares of Globe Life from a “buy” rating to a “hold” rating in a research note on Saturday. Five research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus price target of $124.22.

View Our Latest Research Report on Globe Life

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

See Also

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.